We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$4.7B
AUM Growth
-$944M
Cap. Flow
-$589M
Cap. Flow %
-12.55%
Top 10 Hldgs %
78.54%
Holding
80
New
10
Increased
10
Reduced
26
Closed
20

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$157M
2
TTWO icon
Take-Two Interactive
TTWO
+$102M
3
LEGN icon
Legend Biotech
LEGN
+$85.3M
4
BEKE icon
KE Holdings
BEKE
+$75M
5
ZTO icon
ZTO Express
ZTO
+$56.9M

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$257M
2
PDD icon
Pinduoduo
PDD
+$170M
3
CRM icon
Salesforce
CRM
+$134M
4
DASH icon
DoorDash
DASH
+$118M
5
ONC
BeOne Medicines Ltd
ONC
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 34.72%
2 Consumer Discretionary 30.44%
3 Technology 14.84%
4 Real Estate 11.33%
5 Communication Services 4.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
26
Danaher
DHR
$140B
$20.5M 0.44%
+96,444
New +$20.4M
BMRN icon
27
BioMarin Pharmaceuticals
BMRN
$11.9B
$19.8M 0.42%
228,942
-79,751
-26% -$7.51M
EXAS
28
DELISTED
Exact Sciences
EXAS
$18.6M 0.4%
197,894
+27,800
+16% +$2.17M
KDP icon
29
Keurig Dr Pepper
KDP
$42.5B
$17.7M 0.38%
+564,568
New +$18.5M
FUTU icon
30
Futu Holdings
FUTU
$14.4B
$16.6M 0.35%
417,187
NTES icon
31
NetEase
NTES
$83B
$14.5M 0.31%
149,700
ADBE icon
32
Adobe
ADBE
$105B
$13.2M 0.28%
+27,000
New +$10.9M
AKRO
33
DELISTED
Akero Therapeutics
AKRO
$12.7M 0.27%
273,002
-22,500
-8% -$1.03M
GOOG icon
34
Alphabet (Google) Class C
GOOG
$4.09T
$12.1M 0.26%
+100,000
New +$11.6M
ATAT icon
35
Atour Lifestyle Holdings
ATAT
$4.82B
$10.7M 0.23%
661,522
+183,618
+38% +$3.57M
KNSA icon
36
Kiniksa Pharmaceuticals
KNSA
$6.12B
$9.84M 0.21%
698,741
-319,350
-31% -$4.27M
SOHU
37
Sohu.com
SOHU
$348M
$8.06M 0.17%
731,800
ARGX icon
38
argenx
ARGX
$55.2B
$7.27M 0.15%
+18,665
New +$7.34M
AXSM icon
39
Axsome Therapeutics
AXSM
$11.7B
$7.19M 0.15%
+100,000
New +$7.38M
COIN icon
40
Coinbase
COIN
$43.4B
$7.16M 0.15%
+100,000
New +$5.96M
LI icon
41
Li Auto
LI
$14.4B
$5.99M 0.13%
170,704
-860,268
-83% -$24.2M
GOSS icon
42
Gossamer Bio
GOSS
$92.3M
$5.97M 0.13%
4,974,041
ROIV icon
43
Roivant Sciences
ROIV
$23.6B
$5.28M 0.11%
+523,461
New +$4.68M
AMD icon
44
Advanced Micro Devices
AMD
$701B
$4.61M 0.1%
40,500
-72,600
-64% -$7.55M
EM
45
DELISTED
Smart Share Global Ltd
EM
$3.85M 0.08%
3,949,700
-57,631
-1% -$54.7K
VIPS icon
46
Vipshop
VIPS
$7.24B
$3.28M 0.07%
198,600
-2,106,197
-91% -$33M
AMZN icon
47
Amazon
AMZN
$2.47T
$3.17M 0.07%
24,300
-72,700
-75% -$8.3M
TUYA
48
Tuya Inc
TUYA
$1.05B
$3.02M 0.06%
1,599,700
ALGS icon
49
Aligos Therapeutics
ALGS
$25.7M
$2.24M 0.05%
92,391
MOGU
50
MOGU Inc
MOGU
$17.3M
$2.03M 0.04%
847,510

Similar funds

HHLR Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, HHLR Advisors held 80 positions worth $4.7B, down 17% from $5.64B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

HHLR Advisors withdrew a net $589M in Q2 2023, closing 20 positions and reducing 26 holdings. Its most notable exit was Freeport-McMoran, an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in Take-Two Interactive worth $115M.

  • HHLR Advisors's largest Q2 2023 buy was Take-Two Interactive: 783,000 shares worth $115M.
  • HHLR Advisors added most to Microsoft in Q2 2023, an estimated $157M increase.
  • HHLR Advisors's biggest Q2 2023 reduction was Pinduoduo, cutting an estimated $170M.
  • HHLR Advisors fully exited Freeport-McMoran in Q2 2023, selling an estimated $257M.
  • HHLR Advisors's ten largest holdings make up 79% of its $4.7B portfolio in Q2 2023.
  • HHLR Advisors opened 10 new positions and closed 20 in Q2 2023.
  • HHLR Advisors's portfolio value fell 17% quarter-over-quarter to $4.7B.

Based on HHLR Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.